Ontology highlight
ABSTRACT:
PROVIDER: PRJNA816342 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR18330381.fastq.gz | Fastqsanger.gz | |||
| SRR18330381_1.fastq.gz | Fastqsanger.gz | |||
| SRR18330381_2.fastq.gz | Fastqsanger.gz | |||
| SRR18330382.fastq.gz | Fastqsanger.gz | |||
| SRR18330382_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 9 |
Similar Datasets
Project description:RNA-seq of three brain regions from schizophrenia and bipolar disorder patients and psychiatrically normal individuals
2025-01-24 | E-GEOD-78936 | ExpressionAtlas
Project description:RNA-seq of bone marrow from patients with myelodysplastic syndrome
2025-01-24 | E-GEOD-63816 | ExpressionAtlas
Project description:Epidemiological data have suggested that African Americans (AA) are twice as likely to be diagnosed with multiple myeloma (MM) as compared to European Americans (EA). Here, we have analyzed a set of cytogenetic and genomic data derived from AA and EA MM patients. We have compared the frequency of IgH translocations in a series of data from 115 AA patients from three studies and EA patients from the Eastern Cooperative Oncology Group (ECOG) studies E4A03 and E9487. We have also interrogated tumors from 45 AA and 196 EA MM patients for somatic copy number abnormalities associated with poor outcome. In addition, 35 AA and 178 EA patients were investigated for a transcriptional profile associated with high-risk disease. Overall, based on this cohort, genetic profiles were similar except for a significantly lower frequency of IgH translocations (40% vs. 52%; p=0.032) in AA patients. Frequency differences of somatic copy number aberrations were not significant after correction for multiple testing. There was also no significant difference in the frequency of high-risk disease based upon gene expression profiling. Our study represents the first comprehensive comparisons of the frequency and distribution of molecular alterations in MM tumors between AA and EA patients.
2013-02-25 | GSE44271 | GEO
Project description:RNA-seq of blood from 105 patients with brucellosis, 17 patients with Leishmaniasis and 47 healthy controls
2025-01-24 | E-GEOD-69597 | ExpressionAtlas
Project description:RNA-seq of 359 treatment-naive pediatric patients with Crohn's disease, patients with ulcerative colitis and control individuals
2019-05-14 | E-GEOD-57945 | ExpressionAtlas
Project description:RNA-seq of prostate cancer and adjacent normal tissues from 14 patients
2025-01-23 | E-MTAB-567 | ExpressionAtlas
Project description:Igh/Myc translocations underlie both sporadic Burkitt lymphoma (BL) and the endemic clinical form affecting African children infected with malaria. However, while sporadic translocations decapitate Myc from 5' proximal regulatory elements, most endemic events occur hundreds of kilobases away from Myc. The origin of these rearrangements and how they deregulate oncogenes at such distances remain unclear. Here we recapitulate endemic BL-like translocations in plasmacytomas from uracil N-glycosylase (UNG) deficient mice. We demonstrate that in these animals, rare endemic-like translocations arise from non-targeted DNA breaks at Myc loci. Deep-sequencing analyses revealed that the deregulated 3' Igh enhancer alpha physically interacts with and remodels 0.45Mb of translocated chromatin. The results thus explain the long-range deregulation of oncogenes in human and mouse B cell tumors. ChIP-Seq, 4C, and 1 RNASeq samples used to characterize mouse plasmacytoma cell lines and in vitro activated mouse B cells. Biological replicates are present for many of the samples.
2013-07-04 | E-GEOD-48514 | biostudies-arrayexpress
Project description:RNA-seq comparing transcriptome of lymphoblastic cells from FAME patients and control individuals
2025-01-16 | E-MTAB-8301 | ExpressionAtlas
Project description:RNA-seq of human multiple myeloma patients myeloid-derived suppressor cells (M-MDSC)
2025-01-23 | E-MTAB-9767 | ExpressionAtlas
Project description:Epidemiological data have suggested that African Americans (AA) are twice as likely to be diagnosed with multiple myeloma (MM) as compared to European Americans (EA). Here, we have analyzed a set of cytogenetic and genomic data derived from AA and EA MM patients. We have compared the frequency of IgH translocations in a series of data from 115 AA patients from three studies and EA patients from the Eastern Cooperative Oncology Group (ECOG) studies E4A03 and E9487. We have also interrogated tumors from 45 AA and 196 EA MM patients for somatic copy number abnormalities associated with poor outcome. In addition, 35 AA and 178 EA patients were investigated for a transcriptional profile associated with high-risk disease. Overall, based on this cohort, genetic profiles were similar except for a significantly lower frequency of IgH translocations (40% vs. 52%; p=0.032) in AA patients. Frequency differences of somatic copy number aberrations were not significant after correction for multiple testing. There was also no significant difference in the frequency of high-risk disease based upon gene expression profiling. Our study represents the first comprehensive comparisons of the frequency and distribution of molecular alterations in MM tumors between AA and EA patients. This submission contains 27 of the 45 African American cases analyzed by aCGH. In addition, 196 samples from European American myeloma patients were also analyzed and compared to the 45 African American patients.
2013-02-25 | E-GEOD-44271 | biostudies-arrayexpress